ArticleThe Journal of clinical investigation2019

Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation.

Jianzhou Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.